ANGIODYNAMICS, INC.NEVERTOUCH 600UM FIBER AND VENACURE PROCEDURE KIT

K071959 · AngioDynamics, Inc. · GEX · Aug 1, 2007 · General, Plastic Surgery

Device Facts

Record IDK071959
Device NameANGIODYNAMICS, INC.NEVERTOUCH 600UM FIBER AND VENACURE PROCEDURE KIT
ApplicantAngioDynamics, Inc.
Product CodeGEX · General, Plastic Surgery
Decision DateAug 1, 2007
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 878.4810
Device ClassClass 2
AttributesTherapeutic

Intended Use

The AngioDynamics, Inc. NeverTouch 600μm Fiber is indicated for endovascular coagulation of the great saphenous vein in patients with superficial vein reflux, for the treatment of varicose veins and varicosities associated with superficial reflux of the great saphenous vein, and for the treatment of incompetence and reflux of superficial veins of the lower extremity.

Device Story

NeverTouch 600um Fiber is a laser surgical instrument component used for endovascular coagulation. Device delivers laser energy to target vein tissue to induce thermal coagulation; treats superficial vein reflux and varicose veins. Used in clinical settings by physicians; fiber is inserted into the vein to facilitate ablation. Output is thermal energy; clinical effect is vein closure/coagulation. Benefits include minimally invasive treatment of venous insufficiency.

Clinical Evidence

Bench testing only; no clinical data provided.

Technological Characteristics

Laser surgical fiber; 600μm diameter. Designed for use with laser systems for endovascular coagulation. Non-electronic, passive delivery component. Sterilization via standard medical device methods.

Indications for Use

Indicated for patients with superficial vein reflux, varicose veins, varicosities, and incompetence of the great saphenous vein or superficial veins of the lower extremity.

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus, which is a symbol of medicine, with three lines representing the snakes. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" is arranged in a circular fashion around the caduceus. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 AngioDynamics, Inc. % Ms. Teri Juckett AUG - 1 2007 Regulatory Affairs Manager 603 Queensbury Avenue Queensbury, New York 12804 Re: K071959 Trade/Device Name: AngioDynamics, Inc. NeverTouch 600um Fiber Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: August 11, 2007 Received: August 17, 2007 Dear Ms. Juckett: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {1}------------------------------------------------ Page 2 - Ms. Teri Juckett 'This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrb/industry/support/index.html. Sincerely yours, Mark N. Melkerson Lumm Director DSP D.A Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health 5/1/07 Enclosure {2}------------------------------------------------ ## INDICATIONS FOR USE 510(k) Application: Special 510(k): Device Modification Device Name: AngioDynamics, Inc. NeverTouch 600um Fiber ## Indications for Use: The AngioDynamics, Inc. NeverTouch 600μm Fiber is indicated for endovascular coagulation of the great saphenous vein in patients with superficial vein reflux, for the treatment of varicose veins and varicosities associated with superficial reflux of the great saphenous vein, and for the treatment of incompetence and reflux of superficial veins of the lower extremity. | Prescription Use<br>(Per 21 CFR 801.109) | X | |------------------------------------------|----------------------| | OR | Over-the-Counter Use | (Division Sign-Off) Division of General, Restorative, and Neurological Devices Please do not write below this line - continue on another page if needed 510(k) Number: L071959 Concurrence of CDRH, Office of Device Evaluation (ODE)AngioDynamics NeverTouch 600um Fiber and VenaCure Procedure Kit, 510(k) Design History File 513 Page 7 of 27
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%